151 related articles for article (PubMed ID: 3558985)
1. Interaction of amiodarone and desethylamiodarone with solubilized nuclear thyroid hormone receptors.
Latham KR; Sellitti DF; Goldstein RE
J Am Coll Cardiol; 1987 Apr; 9(4):872-6. PubMed ID: 3558985
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenergic receptors, voltage-operated Ca(2+)-channels, nuclear triiodothyronine receptors and triiodothyronine concentration in pig myocardium after long-term low-dose amiodarone treatment.
Gøtzsche LB
Acta Endocrinol (Copenh); 1993 Oct; 129(4):337-47. PubMed ID: 8237253
[TBL] [Abstract][Full Text] [Related]
3. Effects of desethylamiodarone on thyroid hormone metabolism in rats: comparison with the effects of amiodarone.
Venkatesh N; Al-Sarraf L; Hershman JM; Singh BN
Proc Soc Exp Biol Med; 1986 Feb; 181(2):233-6. PubMed ID: 3945630
[TBL] [Abstract][Full Text] [Related]
4. Thyroxine, 3,5,3'-triiodothyronine, and 3,3',5'-triiodothyronine concentrations in several tissues of the rat: effects of amiodarone and desethylamiodarone on thyroid hormone metabolism [corrected].
Schröder-van der Elst JP; van der Heide D
Endocrinology; 1990 Oct; 127(4):1656-64. PubMed ID: 2401231
[TBL] [Abstract][Full Text] [Related]
5. Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone beta 1-receptor protein.
Bakker O; van Beeren HC; Wiersinga WM
Endocrinology; 1994 Apr; 134(4):1665-70. PubMed ID: 8137729
[TBL] [Abstract][Full Text] [Related]
6. Desethylamiodarone is a competitive inhibitor of the binding of thyroid hormone to the thyroid hormone alpha 1-receptor protein.
van Beeren HC; Bakker O; Wiersinga WM
Mol Cell Endocrinol; 1995 Jul; 112(1):15-9. PubMed ID: 7589780
[TBL] [Abstract][Full Text] [Related]
7. Structure-function relationship of the inhibition of the 3,5,3'-triiodothyronine binding to the alpha1- and beta1-thyroid hormone receptor by amiodarone analogs.
van Beeren HC; Bakker O; Wiersinga WM
Endocrinology; 1996 Jul; 137(7):2807-14. PubMed ID: 8770901
[TBL] [Abstract][Full Text] [Related]
8. Cardiac triiodothyronine nuclear receptor binding capacities in amiodarone-treated, hypo- and hyperthyroid rats.
Gøtzsche LB; Orskov H
Eur J Endocrinol; 1994 Mar; 130(3):281-90. PubMed ID: 8156103
[TBL] [Abstract][Full Text] [Related]
9. Desethylamiodarone antagonizes the effect of thyroid hormone at the molecular level.
Bogazzi F; Bartalena L; Brogioni S; Burelli A; Raggi F; Ultimieri F; Cosci C; Vitale M; Fenzi G; Martino E
Eur J Endocrinol; 2001 Jul; 145(1):59-64. PubMed ID: 11415853
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effects of amiodarone and desethylamiodarone on human thyrocytes.
Beddows SA; Page SR; Taylor AH; McNerney R; Whitley GS; Johnstone AP; Nussey SS
Biochem Pharmacol; 1989 Dec; 38(24):4397-403. PubMed ID: 2604742
[TBL] [Abstract][Full Text] [Related]
11. Distribution of amiodarone and its metabolite, desethylamiodarone, in human tissues.
Brien JF; Jimmo S; Brennan FJ; Ford SE; Armstrong PW
Can J Physiol Pharmacol; 1987 Mar; 65(3):360-4. PubMed ID: 3580958
[TBL] [Abstract][Full Text] [Related]
12. Amiodarone and desethylamiodarone distribution in the atrium and adipose tissue of patients undergoing short- and long-term treatment with amiodarone.
Barbieri E; Conti F; Zampieri P; Trevi GP; Zardini P; d'Aranno V; Latini R
J Am Coll Cardiol; 1986 Jul; 8(1):210-3. PubMed ID: 3711518
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamic studies of amiodarone and its active N-desethyl metabolite.
Nattel S
J Cardiovasc Pharmacol; 1986; 8(4):771-7. PubMed ID: 2427817
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration.
Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA
In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794
[TBL] [Abstract][Full Text] [Related]
15. Desethylamiodarone interferes with the binding of co-activator GRIP-1 to the beta 1-thyroid hormone receptor.
van Beeren HC; Bakker O; Wiersinga WM
FEBS Lett; 2000 Sep; 481(3):213-6. PubMed ID: 11007966
[TBL] [Abstract][Full Text] [Related]
16. The antiarrhythmic efficacy of amiodarone and desethylamiodarone, alone and in combination, in dogs with acute myocardial infarction.
Nattel S; Davies M; Quantz M
Circulation; 1988 Jan; 77(1):200-8. PubMed ID: 2446801
[TBL] [Abstract][Full Text] [Related]
17. Desethylamiodarone prolongation of cardiac repolarization is dependent on gene expression: a novel antiarrhythmic mechanism.
Drvota V; Blange I; Häggblad J; Sylvén C
J Cardiovasc Pharmacol; 1998 Oct; 32(4):654-61. PubMed ID: 9781936
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of amiodarone and desethylamiodarone on calcium antagonist receptors.
Wagner JA; Weisman HF; Levine JH; Snowman AM; Snyder SH
J Cardiovasc Pharmacol; 1990 Mar; 15(3):501-7. PubMed ID: 1691376
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture.
Antonini JM; Reasor MJ
Biochem Pharmacol; 1991 Dec; 42 Suppl():S151-6. PubMed ID: 1768272
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after intravenous administration.
Plomp TA; Wiersinga WM; van Rossum JM; Maes RA
In Vivo; 1989; 3(1):33-47. PubMed ID: 2519831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
